Janux Therapeutics, Inc.
Pharmaceutical company · San Diego, California, United States · Nasdaq: JANX
Janux Therapeutics, Inc. is a pharmaceutical company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2017. Its shares trade on Nasdaq under the ticker JANX. It has reported private securities offerings to the US SEC, most recently $125 million sold in a notice filed in 2021.
Janux Therapeutics at a glance
What does Janux Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $125 million sold (2021).
Frequently asked questions about Janux Therapeutics
Where is Janux Therapeutics headquartered?
Janux Therapeutics, Inc. is headquartered in San Diego, California, United States.
What does Janux Therapeutics do?
Janux Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Janux Therapeutics a public company?
Yes. Janux Therapeutics, Inc. trades on Nasdaq under the ticker JANX.
When was Janux Therapeutics founded?
The earliest incorporation on record for Janux Therapeutics, Inc. is in 2017, according to public company registers.
Similar companies
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Oncternal Therapeutics, Inc.San Diego, California, United States
- Acadia Pharmaceuticals IncSan Diego, California, United States
- ViaCyte Inc.San Diego, California, United States
- Avidity Biosciences, Inc.San Diego, California, United States
- Ligand Pharmaceuticals IncSan Diego, California, United States
- Arena Pharmaceuticals IncSan Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.